Cell · 2026
MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybrids.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Uhl Leonie, Aziba Amel, Löbbert Sinah, Russell Timothy, Krenz Bastian, Montesinos Francisco, Kannan Toshitha, Valanju Omkar R, Schülein-Völk Christina, de Martines Tim, Bolz Michael, Fleischhauer Daniel, Cossa Giacomo, Endres Theresa, Solvie Daniel, Gallant Peter, Rosenwald Andreas, Maric Hans M, Papadopoulos Dimitrios, Vos Seychelle M, Eilers Martin
Аннотация
In response to perturbed transcription elongation, the MYC oncoprotein multimerizes and undergoes a phase transition. Here, we demonstrate that MYC globally relocalizes from its canonical positions on DNA to nascent RNA upon accumulation of intronic RNA. Upon binding to RNA, MYC forms multimers that concentrate the nuclear exosome, an RNA exonuclease, and its targeting complexes around double-stranded RNA and R-loops. MYC harbors four RNA-binding regions (RBRI-IV). RBRIII promotes MYC multimerization and is necessary for recruiting the exosome to R-loops. RBRIII is dispensable for transcriptional activation and pancreatic tumor cell proliferation in culture, but it is indispensable for sustaining tumor growth in vivo. Via RBRIII, MYC suppresses the accumulation of R-loop-derived RNA-DNA hybrids and prevents them from activating the innate immune kinase TBK1 via the TLR3 pattern recognition receptor. Our data demonstrate that the phase transition of MYC is an RNA-driven stress response that suppresses the accumulation of immunogenic RNA-DNA hybrids.